{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:19:57Z","timestamp":1785392397489,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vph.2009.11.001","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T09:06:54Z","timestamp":1259572014000},"page":"55-62","source":"Crossref","is-referenced-by-count":17,"title":["Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model"],"prefix":"10.1016","volume":"52","author":[{"given":"Enrico","family":"Jandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Mutschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Mahboobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Uecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Platz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank-D.","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans R.","family":"Figulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2009.11.001_bib1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.91.11.2793","article-title":"Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery","volume":"91","author":"Asahara","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.97.19.1960","article-title":"PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine","volume":"97","author":"Banai","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cardiores.2004.06.013","article-title":"Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries","volume":"64","author":"Banai","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2009.11.001_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biomaterials.2004.02.040","article-title":"Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries","volume":"26","author":"Banai","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.vph.2009.11.001_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0033-0620(97)80003-5","article-title":"The biology of restenosis","volume":"40","author":"Bauters","year":"1997","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2009.11.001_bib6","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1161\/01.CIR.99.25.3292","article-title":"Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A","volume":"99","author":"Bilder","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00005344-200306000-00001","article-title":"Stent-induced restenosis in the swine coronary artery is inhibited by a platelet-derived growth factor receptor tyrosine kinase inhibitor, TKI963","volume":"41","author":"Bilder","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2009.11.001_bib8","first-page":"55","article-title":"Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher)","volume":"56","author":"Biondi-Zoccai","year":"2008","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.vph.2009.11.001_bib9","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/0735-1097(94)90126-0","article-title":"Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model","volume":"24","author":"Carter","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2009.11.001_bib10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2005.02.062","article-title":"PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2009.11.001_bib11","first-page":"CD002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","author":"Dorffler-Melly","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.vph.2009.11.001_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJM199812033392304","article-title":"Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group","volume":"339","author":"Erbel","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2009.11.001_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1653454","article-title":"Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF","volume":"253","author":"Ferns","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.vph.2009.11.001_bib14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/hq0901.095567","article-title":"Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model","volume":"21","author":"Fishbein","year":"2001","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2009.11.001_bib15","first-page":"723","article-title":"A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty","volume":"13","author":"Grassman","year":"2001","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.vph.2009.11.001_bib16","first-page":"269","article-title":"Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo","volume":"19","author":"Hacker","year":"2007","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.vph.2009.11.001_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.13.8.1218","article-title":"Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury","volume":"13","author":"Jackson","year":"1993","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/j.vph.2009.11.001_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2009.11.001_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00380-004-0768-6","article-title":"Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model","volume":"19","author":"Kim","year":"2004","journal-title":"Heart Vessels"},{"key":"10.1016\/j.vph.2009.11.001_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1248\/bpb.30.805","article-title":"Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase","volume":"30","author":"Kim","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.vph.2009.11.001_bib21","first-page":"330","article-title":"Drug-eluting stents: immediate and long-term results","volume":"46","author":"Korovesis","year":"2005","journal-title":"Hellenic J. Cardiol."},{"key":"10.1016\/j.vph.2009.11.001_bib22","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1161\/01.ATV.20.11.e89","article-title":"Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model","volume":"20","author":"Leppanen","year":"2000","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2009.11.001_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.CIR.0000117234.08626.7C","article-title":"Oral imatinib mesylate (STI571\/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits","volume":"109","author":"Leppanen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cardiores.2004.08.008","article-title":"PDGF receptor kinase inhibitors for the treatment of restenosis","volume":"65","author":"Levitzki","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2009.11.001_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.fjc.0000246940.91191.1f","article-title":"Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery","volume":"48","author":"Li","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2009.11.001_bib26","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/01.CIR.0000071083.31270.C3","article-title":"Endothelial recovery: the next target in restenosis prevention","volume":"107","author":"Losordo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/jm010988n","article-title":"Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase","volume":"45","author":"Mahboobi","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vph.2009.11.001_bib28","doi-asserted-by":"crossref","unstructured":"Mehilli, Kastrati, Wessely, Dibra, Hausleiter, Jaschke, Dirschinger, Schomig, 2006. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation Jan 17;113(2):273\u20139.","DOI":"10.1161\/CIRCULATIONAHA.105.575977"},{"key":"10.1016\/j.vph.2009.11.001_bib29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.ATV.17.7.1283","article-title":"PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery","volume":"17","author":"Panek","year":"1997","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2009.11.001_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/187152508783955051","article-title":"Drug-eluting stents: present and future","volume":"6","author":"Pendyala","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.vph.2009.11.001_bib31","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.ATV.15.12.2254","article-title":"Expression and function of a recombinant PDGF B gene in porcine arteries","volume":"15","author":"Pompili","year":"1995","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2009.11.001_bib32","first-page":"S87","article-title":"Smooth muscle migration in atherosclerosis and restenosis","volume":"100","author":"Schwartz","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2009.11.001_bib33","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/01.CIR.0000033485.20594.6F","article-title":"Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group","volume":"106","author":"Schwartz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2009.11.001_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/14628840310017177","article-title":"Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement","volume":"5","author":"Serruys","year":"2003","journal-title":"Int. J. Cardiovasc. Interv."},{"key":"10.1016\/j.vph.2009.11.001_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2004.02.001","article-title":"Biological aspects of radiation and drug-eluting stents for the prevention of restenosis","volume":"63","author":"Sindermann","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2009.11.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.crd.0000200844.16899.fc","article-title":"Drug-eluting stents: preventing restenosis","volume":"15","author":"Slavin","year":"2007","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.vph.2009.11.001_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/07853890801964948","article-title":"Drug-eluting stents \u2014 what should be improved?","volume":"40","author":"Steffel","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.vph.2009.11.001_bib38","first-page":"127","article-title":"Drug-eluting stent thrombosis","volume":"56","author":"Steinberg","year":"2008","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.vph.2009.11.001_bib39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2009.11.001_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mhj.2003.63","article-title":"A randomized trial assessing the effect of coumarins started before coronary angioplasty on restenosis: results of the 6-month angiographic substudy of the Balloon Angioplasty and Anticoagulation Study (BAAS)","volume":"145","author":"ten Berg","year":"2003","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2009.11.001_bib41","first-page":"831","article-title":"In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty","volume":"149","author":"Ueda","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2009.11.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ccd.20437","article-title":"Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents","volume":"67","author":"Werner","year":"2006","journal-title":"Catheter Cardiovasc. Interv."},{"key":"10.1016\/j.vph.2009.11.001_bib43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.RES.88.6.630","article-title":"Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis","volume":"88","author":"Yamasaki","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2009.11.001_bib44","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jacc.2005.07.060","article-title":"A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib","volume":"46","author":"Zohlnhofer","year":"2005","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T03:40:31Z","timestamp":1558669231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189109001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1537189109001463"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2009.11.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}